HALEOS LABS
Back to Balance Sheet
|
HALEOS LABS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹11 Cr | ₹12 Cr | ₹13 Cr | ₹11 Cr | ₹11 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of HALEOS LABS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹11 Cr |
| Mar2024 | ₹12 Cr |
| Mar2023 | ₹13 Cr |
| Mar2022 | ₹11 Cr |
| Mar2021 | ₹11 Cr |
How is Deferred Tax Assets / Liabilities of HALEOS LABS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹11 Cr | -10.84 | |
| Mar2024 | ₹12 Cr | -5.62 | |
| Mar2023 | ₹13 Cr | 19.44 | |
| Mar2022 | ₹11 Cr | -1.32 | |
| Mar2021 | ₹11 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of HALEOS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HALEOS LABS | ₹456.7 Cr | -4.9% | 9.9% | 18.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹474,396.0 Cr | 1.8% | 5.6% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,990.0 Cr | 0.5% | 13.1% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,354.0 Cr | -2.7% | 5.1% | 42.4% | Stock Analytics | |
| CIPLA | ₹116,705.0 Cr | 2.1% | -0.6% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹94,790.0 Cr | -4% | -17.5% | -8.6% | Stock Analytics | |
HALEOS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HALEOS LABS | -4.9% |
9.9% |
18.3% |
| SENSEX | -0.9% |
-0.4% |
-6.1% |
You may also like the below Video Courses